Devon R S, Orban P C, Gerrow K, Barbieri M A, Schwab C, Cao L P, Helm J R, Bissada N, Cruz-Aguado R, Davidson T-L, Witmer J, Metzler M, Lam C K, Tetzlaff W, Simpson E M, McCaffery J M, El-Husseini A E, Leavitt B R, Hayden M R
Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, 980 West 28th Avenue, Vancouver, BC, Canada V5Z 4H4.
Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9595-600. doi: 10.1073/pnas.0510197103. Epub 2006 Jun 12.
ALS2 is an autosomal recessive form of spastic paraparesis (motor neuron disease) with juvenile onset and slow progression caused by loss of function of alsin, an activator of Rac1 and Rab5 small GTPases. To establish an animal model of ALS2 and derive insights into the pathogenesis of this illness, we have generated alsin-null mice. Cytosol from brains of Als2(-/-) mice shows marked diminution of Rab5-dependent endosome fusion activity. Furthermore, primary neurons from Als2(-/-) mice show a disturbance in endosomal transport of insulin-like growth factor 1 (IGF1) and BDNF receptors, whereas neuronal viability and endocytosis of transferrin and dextran seem unaltered. There is a significant decrease in the size of cortical motor neurons, and Als2(-/-) mice are mildly hypoactive. Altered trophic receptor trafficking in neurons of Als2(-/-) mice may underlie the histopathological and behavioral changes observed and the pathogenesis of ALS2.
肌萎缩侧索硬化2型(ALS2)是一种常染色体隐性遗传的痉挛性截瘫(运动神经元疾病),发病于青少年期,进展缓慢,由Rac1和Rab5小GTP酶的激活剂alsin功能丧失所致。为建立ALS2动物模型并深入了解该疾病的发病机制,我们培育出了alsin基因敲除小鼠。Als2(-/-)小鼠脑内的胞质溶胶显示出Rab5依赖的内体融合活性显著降低。此外,Als2(-/-)小鼠的原代神经元在胰岛素样生长因子1(IGF1)和脑源性神经营养因子(BDNF)受体的内体运输方面存在紊乱,而神经元活力以及转铁蛋白和葡聚糖的内吞作用似乎未受影响。皮质运动神经元的大小显著减小,且Als2(-/-)小鼠的活动轻度减少。Als2(-/-)小鼠神经元中营养受体运输的改变可能是所观察到的组织病理学和行为变化以及ALS2发病机制的基础。